These results indicate that PN’s inhibitory effect on AD-like skin lesions may result from modulating MAPK phosphorylation and activating NF-κB and STATs in TNF-α/IFN-γ-induced HaCaT keratinocytes. The gene discussed is NFKB1; the disease is Alzheimer disease.